The Therapeutic Goods Administration has fined individual Australians almost $16,000 for allegedly unlawfully importing prescription medicines, including tirzepatide, erectile dysfunction drugs, and cosmetic injectables.
The penalties were among 12 infringement notices worth a combined $126,720 issued to two companies and five individuals for alleged breaches of the Therapeutic Goods Act.
The largest penalty went to the Australian Centre for Functional Medicine Pty Ltd, which paid $59,400 across three infringement notices relating to the importation of unapproved melatonin products.
The TGA did not provide details about the formulations, strengths, or quantities of melatonin involved, or whether the products had been supplied to patients.
Chan and Khin Pty Ltd and a Queensland-based health practitioner were issued four infringement notices totalling $47,520 over the advertising of prescription medicines including lovastatin, baricitinib, and ketamine.
But the enforcement action also extended directly to individual importers.



